Skip to main content
Clinical Trials/NCT00102869
NCT00102869
Completed
Phase 4

Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Aphasia)

University Hospital Muenster1 site in 1 country12 target enrollmentJanuary 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cerebrovascular Accident
Sponsor
University Hospital Muenster
Enrollment
12
Locations
1
Primary Endpoint
Boost in naming performance (percent correct) through levodopa as compared to placebo
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether levodopa, in combination with a high frequency language training, is effective in boosting naming performance in patients with aphasia.

Detailed Description

Our prior work shows that d-amphetamine and the dopamine precursor levodopa markedly improve word learning success in healthy subjects. In this randomized, placebo-controlled, double-blind clinical trial, we probe whether daily administration of levodopa, coupled with several hours of language training every day, will significantly improve naming abilities in patients with aphasia as compared to placebo administration. We furthermore examine with magnetic resonance imaging which brain regions need to be functionally intact for a dopaminergic improvement of language therapy.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
December 2008
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital Muenster

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Boost in naming performance (percent correct) through levodopa as compared to placebo

Time Frame: immediately after each treatmentphase

Brain activity pattern in successfully trained patients

Time Frame: immediately after each treatmentphase

Secondary Outcomes

  • Stability of naming performance after one month and six months post treatment(from 1 month untill 6 months after treatment completion)

Study Sites (1)

Loading locations...

Similar Trials